Savvy measurement and reporting of the global effects of CDI programs on quality have become particularly important as the investment in CDI resources continues to grow across the nation.
Patient safety is an organizational responsibility. But concern over the astonishing rate of development and adoption of EHRs in recent years has also provided potential for risk and safety issues.
As the value-based care model is moving towards paying for performance, there must be standards for improved quality of care and quantifying the rate of reduction in healthcare costs.
On Monday afternoon AHIMA Board of Directors President Ann Chenoweth, MBA, RHIA, FAHIMA, announced a change in AHIMA’s leadership, stating that former CEO Lynne Thomas Gordon’s last day with AHIMA was July 15.
It is important to know the difference between anticoagulant drugs and antiplatelet drugs when assigning a Z-code for long term drug use.